ELF1
Basic information
Region (hg38): 13:40931919-41061440
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ELF1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 32 | 32 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 32 | 0 | 2 |
Variants in ELF1
This is a list of pathogenic ClinVar variants found in the ELF1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
13-40933443-C-T | Benign (Sep 11, 2018) | |||
13-40933447-A-T | not specified | Uncertain significance (May 03, 2023) | ||
13-40933449-T-A | not specified | Uncertain significance (May 24, 2023) | ||
13-40933450-T-G | not specified | Uncertain significance (May 24, 2023) | ||
13-40933519-G-A | not specified | Uncertain significance (Oct 17, 2023) | ||
13-40933528-T-C | not specified | Uncertain significance (Feb 27, 2023) | ||
13-40933633-G-A | not specified | Uncertain significance (Jun 29, 2022) | ||
13-40933636-C-T | not specified | Uncertain significance (Nov 09, 2021) | ||
13-40933682-C-T | not specified | Uncertain significance (May 13, 2024) | ||
13-40933688-G-A | not specified | Uncertain significance (Jun 07, 2023) | ||
13-40933727-C-T | not specified | Uncertain significance (Feb 06, 2023) | ||
13-40933753-T-C | not specified | Uncertain significance (May 03, 2023) | ||
13-40933759-G-T | not specified | Uncertain significance (May 25, 2022) | ||
13-40933853-T-C | not specified | Uncertain significance (Apr 09, 2024) | ||
13-40933890-C-A | not specified | Uncertain significance (Oct 13, 2023) | ||
13-40933988-G-A | not specified | Uncertain significance (Feb 17, 2022) | ||
13-40934006-C-T | not specified | Uncertain significance (May 30, 2024) | ||
13-40941021-C-G | not specified | Uncertain significance (Dec 28, 2023) | ||
13-40941053-T-A | not specified | Uncertain significance (Nov 21, 2023) | ||
13-40941066-C-T | not specified | Uncertain significance (Jan 10, 2023) | ||
13-40941071-C-T | not specified | Uncertain significance (Mar 23, 2022) | ||
13-40941085-T-A | Benign (Feb 12, 2018) | |||
13-40941101-A-C | not specified | Uncertain significance (May 18, 2022) | ||
13-40941137-G-A | not specified | Uncertain significance (Jul 14, 2021) | ||
13-40941188-C-T | not specified | Uncertain significance (Nov 18, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ELF1 | protein_coding | protein_coding | ENST00000239882 | 8 | 129521 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0106 | 0.989 | 125730 | 0 | 18 | 125748 | 0.0000716 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.914 | 279 | 325 | 0.857 | 0.0000165 | 4008 |
Missense in Polyphen | 65 | 107.06 | 0.60713 | 1404 | ||
Synonymous | 0.466 | 114 | 121 | 0.946 | 0.00000674 | 1245 |
Loss of Function | 3.12 | 8 | 24.7 | 0.324 | 0.00000123 | 305 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000615 | 0.0000615 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.0000953 | 0.0000924 |
European (Non-Finnish) | 0.0000970 | 0.0000967 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.0000665 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Transcription factor that activates the LYN and BLK promoters. Appears to be required for the T-cell-receptor-mediated trans activation of HIV-2 gene expression. Binds specifically to two purine-rich motifs in the HIV-2 enhancer. {ECO:0000269|PubMed:8756667}.;
- Pathway
- Gene expression (Transcription);Generic Transcription Pathway;RNA Polymerase II Transcription;RUNX1 regulates transcription of genes involved in BCR signaling;Angiopoietin receptor Tie2-mediated signaling;RUNX1 regulates transcription of genes involved in interleukin signaling;Transcriptional regulation by RUNX1;IL2 signaling events mediated by STAT5;AP-1 transcription factor network;Regulation of retinoblastoma protein
(Consensus)
Recessive Scores
- pRec
- 0.115
Intolerance Scores
- loftool
- 0.501
- rvis_EVS
- 0.31
- rvis_percentile_EVS
- 72.71
Haploinsufficiency Scores
- pHI
- 0.768
- hipred
- Y
- hipred_score
- 0.758
- ghis
- 0.509
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 1.00
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | High | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Elf1
- Phenotype
- hematopoietic system phenotype; immune system phenotype;
Gene ontology
- Biological process
- regulation of cytokine production;regulation of cytokine-mediated signaling pathway;regulation of transcription by RNA polymerase II;cell differentiation;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;regulation of B cell receptor signaling pathway;negative regulation of T cell receptor signaling pathway
- Cellular component
- nucleus;nucleoplasm
- Molecular function
- RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA-binding transcription factor activity;protein binding